Display options
Share it on

ACR Open Rheumatol. 2020 Feb;2(2):74-78. doi: 10.1002/acr2.11105. Epub 2020 Jan 06.

Thyroid Disease in Lupus: An Updated Review.

ACR open rheumatology

Yael Klionsky, Maria Antonelli

Affiliations

  1. Case Western Reserve University at MetroHealth Medical Center, Cleveland, Ohio.

PMID: 32043833 PMCID: PMC7011406 DOI: 10.1002/acr2.11105

Abstract

In the following review, we seek to provide an overview of the current understanding of various thyroid manifestations affecting patients with systemic lupus erythematosus (SLE), including topics ranging from thyroid-related complications to SLE in pregnancy. Autoimmune diseases tend to coincide, and an association between thyroid disease and SLE has been reported for more than 50 years. There is no evidence that the coexistence of thyroid disease and lupus alters the disease course or manifestations of either. Both hypothyroidism and thyroid nodules are seen more frequently in patients with SLE than in the general population. The rate of thyroid cancer is twice as prevalent in patients with SLE compared with those without SLE. Several forms of thyroid disease are more common among patients with SLE, with adverse consequences in pregnancy. Future work will require delineating the mechanism behind these associations and understanding the role of antirheumatic agents with concomitant thyroid disease.

© 2020 The Authors. ACR Open Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology.

References

  1. J Microbiol Immunol Infect. 2015 Dec;48(6):676-83 - PubMed
  2. Int J Clin Exp Pathol. 2014 Aug 15;7(9):6270-3 - PubMed
  3. N Engl J Med. 1995 Dec 21;333(25):1688-94 - PubMed
  4. Nat Med. 2010 Jun;16(6):701-7 - PubMed
  5. Autoimmun Rev. 2014 Mar;13(3):272-80 - PubMed
  6. Int J Endocrinol. 2017;2017:5940367 - PubMed
  7. Am J Med. 2010 Feb;123(2):183.e1-9 - PubMed
  8. J Clin Endocrinol Metab. 2002 Feb;87(2):489-99 - PubMed
  9. J Clin Endocrinol Metab. 2010 Jan;95(1):314-8 - PubMed
  10. Isr Med Assoc J. 2004 Apr;6(4):218-20 - PubMed
  11. Front Endocrinol (Lausanne). 2017 Jul 21;8:175 - PubMed
  12. Int J Clin Exp Med. 2014 Sep 15;7(9):2836-43 - PubMed
  13. J Clin Invest. 1970 Oct;49(10):1922-9 - PubMed
  14. J Rheumatol. 1991 Aug;18(8):1193-5 - PubMed
  15. Br J Rheumatol. 1995 Apr;34(4):361-4 - PubMed
  16. Iran J Allergy Asthma Immunol. 2017 Feb;16(1):72-76 - PubMed
  17. Clin Rheumatol. 2007 Nov;26(11):1891-4 - PubMed
  18. PLoS One. 2015 Apr 17;10(4):e0122964 - PubMed
  19. Glob Pediatr Health. 2017 Oct 16;4:2333794X17736700 - PubMed
  20. Lupus. 2011 Oct;20(10):1035-41 - PubMed
  21. Lupus. 2018 Nov;27(13):2120-2128 - PubMed
  22. Endocr Pract. 2014 Jun;20(6):589-96 - PubMed
  23. Intern Med. 2012;51(16):2189-92 - PubMed
  24. Endocr Pract. 2017 Nov;23(11):1304-1310 - PubMed
  25. Lancet Diabetes Endocrinol. 2015 Oct;3(10):816-25 - PubMed
  26. Lupus. 2011 Jun;20(7):690-9 - PubMed
  27. Birth Defects Res B Dev Reprod Toxicol. 2014 Aug;101(4):300-7 - PubMed
  28. Lupus. 2013 Dec;22(14):1509-13 - PubMed
  29. Thyroid. 1997 Feb;7(1):125-32 - PubMed
  30. J Reprod Immunol. 2016 Apr;114:32-7 - PubMed
  31. Rheumatol Int. 2012 Jan;32(1):73-8 - PubMed
  32. J Clin Invest. 1969 Nov;48(11):2096-103 - PubMed
  33. Endocrine. 2012 Oct;42(2):252-65 - PubMed
  34. Rheum Dis Clin North Am. 2014 Aug;40(3):497-506, viii - PubMed
  35. Rheumatology (Oxford). 2001 Mar;40(3):353-4 - PubMed
  36. J Clin Endocrinol Metab. 1987 Oct;65(4):689-96 - PubMed
  37. Metabolism. 2010 Jun;59(6):896-900 - PubMed
  38. Arthritis Rheum. 1987 Oct;30(10):1124-31 - PubMed
  39. Curr Opin Rheumatol. 2015 Sep;27(5):454-60 - PubMed
  40. Autoimmun Rev. 2016 May;15(5):484-6 - PubMed
  41. PLoS One. 2015 Apr 23;10(4):e0123291 - PubMed
  42. Clin Exp Dermatol. 1995 Jul;20(4):345-7 - PubMed
  43. Multidiscip Respir Med. 2012 Jul 17;7(1):14 - PubMed
  44. Arthritis Rheum. 2005 Aug;52(8):2396-402 - PubMed
  45. Lancet. 1961 Feb 18;1(7173):368-73 - PubMed

Publication Types